Table 3.
Multiple logistic regression models of the association between triglyceride categories and likelihood of ≥20% ASCVD risk overall and by statin use.
| Overall Adjusted OR (95%) | Statin Users Adjusted OR (95%) | Non-statin Users Adjusted OR (95%) | |
|---|---|---|---|
| Model 1 - Adjusted for age, gender, ethnicity (n = 4986) | |||
| <70 mg/dL | Reference | ||
| 70-<100 | 1.64 (1.06–2.52)∗ | 1.76 (0.93–3.34) | 1.61 (0.94–2.78) |
| 100-<135 | 2.42 (1.51–3.88)∗∗ | 2.74 (1.45–5.19)∗∗ | 2.33 (1.29–4.23)∗∗ |
| 135-<150 | 5.00 (2.79–8.96)∗∗∗ | 5.25 (2.38–11.57)∗∗∗ | 4.95 (2.20–11.15)∗∗ |
| 150-<200 | 4.90 (2.66–9.02)∗∗∗ | 4.42 (2.05–9.54)∗∗ | 5.31 (2.72–10.36)∗∗∗ |
| >=200 | 9.47 (6.27–14.29)∗∗∗ | 8.83 (3.90–19.98)∗∗∗ | 10.00 (6.10–16.39)∗∗∗ |
| Model 2 - Adjusted for age, DM, SBP, gender, current smoking, hypertension medication, ethnicity, and LDL-C (n = 4889) | |||
| <70 mg/dL | Reference | ||
| 70-<100 | 1.69 (0.77–3.70) | 2.42 (0.64–9.20) | 1.35 (0.49–3.69) |
| 100-<135 | 2.19 (1.00–4.77)∗ | 3.82 (1.32–11.07)∗ | 1.68 (0.58–4.90) |
| 135-<150 | 6.69 (2.71–16.48)∗∗∗ | 8.94 (2.79–28.69)∗∗ | 5.08 (1.34–19.19)∗ |
| 150-<200 | 5.07 (2.14–12.01)∗∗ | 7.28 (2.14–24.70)∗∗ | 3.59 (1.12–11.53)∗ |
| >=200 | 7.48 (3.09–18.12)∗∗∗ | 8.50 (2.64–27.41)∗∗ | 6.44 (1.75–23.75)∗∗ |
| Model 3 - Adjusted for age, DM, SBP, gender, current smoking, hypertension medication, ethnicity, LDL-C and HDL-C (n = 4889) | |||
| <70 mg/dL | Reference | ||
| 70-<100 | 1.48 (0.66–3.33) | 2.24 (0.59–8.57) | 1.15 (0.41–3.25) |
| 100-<135 | 1.51 (0.67–3.41) | 3.40 (1.13–10.29)∗ | 0.95 (0.33–2.78) |
| 135-<150 | 4.57 (1.91–10.91)∗∗ | 8.07 (2.23–29.20)∗∗ | 2.79 (0.79–9.92) |
| 150-<200 | 3.12 (1.25–7.81)∗ | 6.32 (1.67–23.83)∗∗ | 1.69 (0.48–5.94) |
| >=200 | 3.68 (1.39–9.75)∗∗ | 6.80 (1.64–28.29)∗∗ | 2.18 (0.57–8.30) |
| Model 4 - Adjusted for age, DM, SBP, gender, current smoking, hypertension medication, ethnicity, non-HDL-C and HDL-C (n = 4889) | |||
| <70 mg/dL | Reference | Reference | Reference |
| 70-<100 | 1.22 (0.55–2.72) | 1.74 (0.44–6.87) | 0.96 (0.34–2.71) |
| 100-<135 | 0.97 (0.43–2.21) | 2.12 (0.67–6.74) | 0.60 (0.20–1.80) |
| 135-<150 | 2.38 (1.03–5.51) | 3.92 (1.01–15.14) | 1.46 (0.43–4.99) |
| 150-<200 | 1.38 (0.53–3.55) | 2.48 (0.63–9.76) | 0.77 (0.21–2.85) |
| >=200 | 1.30 (0.49–3.43) | 2.18 (0.51–9.43) | 0.75 (0.19–2.90) |
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.0001.97 subjects had missing values of LDL-C.